| Identification | Back Directory | [Name]
N3-(7-Cyclobutyl-3-phenyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-N1,N1,2,2-tetramethyl-1,3-propanediamine | [CAS]
473382-39-7 | [Synonyms]
Akt-l-1
Akt-I-1
Akt-I-1 (Akti-1)
N1-(7-Cyclobutyl-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-N3,N3,2,2-tetramethylpropane-1
N3-(7-Cyclobutyl-3-phenyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-N1,N1,2,2-tetramethyl-1,3-propanediamine
N1-(7-Cyclobutyl-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-N3,N3,2,2-tetramethylpropane-1,3-diamine
1,3-Propanediamine, N3-(7-cyclobutyl-3-phenyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-N1,N1,2,2-tetramethyl-
1,3-PropanediaMine, N'-(7-cyclobutyl-3-phenyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-N,N,2,2-tetraMethyl- (9CI) | [Molecular Formula]
C22H30N6 | [MDL Number]
MFCD16038643 | [MOL File]
473382-39-7.mol | [Molecular Weight]
378.51 |
| Hazard Information | Back Directory | [Uses]
Akt-I-1 is a reversible inhibitor of serine/threonine protein kinase AKT, and has been shown to induce apoptosis in LNCap prostate cancer cells. |
|
| Company Name: |
NCE Biomedical Co.,Ltd.
|
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList15748/0.htm |
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
|